c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells

Journal of Medical Virology

Volumn 85, Issue 6, 2013, Pages 969-978

  Jung, Yong Jin ^a,b   Kim, Jin Wook ^a,c   Park, Soo Jin ^d   Min, Bo Young ^c   Jang, Eun Sun ^a,c   Kim, Nam Young ^c   Jeong, Sook Hyang ^a,c   Shin, Cheol Min ^a,c   Lee, Sang Hyub ^a,c   Park, Young Soo ^a,c   Hwang, Jin Hyeok ^a,c   Kim, Nayoung ^a,c   Lee, Dong Ho ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

C Myc; Hepatitis B virus; MiR 17 92

Indexed keywords

MICRORNA; MICRORNA 17 5P; MICRORNA 18A; MICRORNA 19A; MICRORNA 19B; MICRORNA 20A; MICRORNA 92A 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HEPATITIS B; HEPATOMA CELL; HUMAN; HUMAN CELL; ONCOGENE C MYC; PROTEIN EXPRESSION; VIRUS REPLICATION;

BASE SEQUENCE; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION; GENOME, VIRAL; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER NEOPLASMS; MICRORNAS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 84876378029     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23534     Document Type: Article

References (64)

1. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB. 2008. MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 105: 19678-19683.
2. Avantaggiati ML, Balsano C, Natoli G, De Marzio E, Will H, Elfassi E, Levrero M. 1992. The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factors. Arch Virol 4: 57-61.
3. Balsano C, Avantaggiati ML, Natoli G, De Marzio E, Will H, Perricaudet M, Levrero M. 1991. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. Biochem Biophys Res Commun 176: 985-992.
4. Chan KL, Guan XY, Ng IO. 2004. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma. Hum Pathol 35: 1324-1331.
5. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. 2005. Real-time quantification of microRNAs by stem-loo pRT-PCR. Nucleic Acids Res 33: e179.
6. Chen Y, Shen A, Rider PJ, Yu Y, Wu K, Mu Y, Hao Q, Liu Y, Gong H, Zhu Y, Liu F, Wu J. 2011. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J 25: 4511-4521.
7. Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T, Rogler CE. 2008. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 173: 856-864.
8. Ehlers I, Horke S, Reumann K, Rang A, Grosse F, Will H, Heise T. 2004. Functional characterization of the interaction between human La and hepatitis B virus RNA. J Biol Chem 279: 43437-43447.
9. Guo H, Liu H, Mitchelson K, Rao H, Luo M, Xie L, Sun Y, Zhang L, Lu Y, Liu R, Ren A, Liu S, Zhou S, Zhu J, Zhou Y, Huang A, Wei L, Guo Y, Cheng J. 2011. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology 54: 808-819.
10. Haasnoot J, Berkhout B. 2011. RNAi and cellular miRNAs in infections by mammalian viruses. Methods Mol Biol 721: 23-41.
11. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. 2005. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
12. He L, Hannon GJ. 2004. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
13. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
14. Heise T, Sommer G, Reumann K, Meyer I, Will H, Schaal H. 2006. The hepatitis B virus PRE contains a splicing regulatory element. Nucleic Acids Res 34: 353-363.
15. Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, Fehr C, Junemann C, Niepmann M. 2008. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27: 3300-3310.
16. Huang ZM, Yen TS. 1994. Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm. J Virol 68: 3193-3199.
17. Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13: 1241-1247.
18. Huang J, Wang Y, Guo Y, Sun S. 2010. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 52: 60-70.
19. Ji M, Rao E, Ramachandrareddy H, Shen Y, Jiang C, Chen J, Hu Y, Rizzino A, Chan WC, Fu K, McKeithan TW. 2011. The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies. Am J Pathol 179: 1645-1656.
20. Jiang J, Lee EJ, Gusev Y, Schmittgen TD. 2005. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403.
21. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.
22. Kim JW, Zhang YH, Zern MA, Rossi JJ, Wu J. 2007. Short hairpin RNA causes the methylation of transforming growth factor-[beta] receptor II promoter and silencing of the target gene in rat hepatic stellate cells. Biochem Biophys Res Commun 359: 292-297.
23. Kim JW, Lee S, Park Y, Hwang JH, Jeong SH, Kim N, Lee D. 2011. Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection. Intervirology 54: 316-325.
24. Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X. 2011. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS ONE 6: e19518.
25. Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW. 1997. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 41: 1715-1720.
26. Laras A, Koskinas J, Hadziyannis SJ. 2002. In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter. Virology 295: 86-96.
27. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97-107.
28. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. 2009. Control of cccDNA function in hepatitis B virus infection. J Hepatol 51: 581-592.
29. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
30. Li MJ, Rossi JJ. 2005. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes. Methods Enzymol 392: 218-226.
31. Li X, Chen S, Feng J, Deng H, Sun R. 2010. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency. J Virol 84: 8945-8948.
32. Lok AS, McMahon BJ. 2009. Chronic hepatitis B: Update 2009. Hepatology 50: 661-662.
33. Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H, Yamada H, Suzuki M, Nagino M, Nimura Y. 2007. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26: 6099-6105.
34. McMahon BJ. 2009. The natural history of chronic hepatitis B virus infection. Hepatology 49: S45-S55.
35. Mendell JT. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
36. Mi S, Li Z, Chen P, He C, Cao D, Elkahloun A, Lu J, Pelloso LA, Wunderlich M, Huang H, Luo RT, Sun M, He M, Neilly MB, Zeleznik-Le NJ, Thirman MJ, Mulloy JC, Liu PP, Rowley JD, Chen J. 2010. Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc Natl Acad Sci USA 107: 3710-3715.
37. Mitas M, Mikhitarian K, Walters C, Baron PL, Elliott BM, Brothers TE, Robison JG, Metcalf JS, Palesch YY, Zhang Z. 2001. Quantitative real time RT PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 93: 162-171.
38. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
39. Oh SY, Ju Y, Park H. 2009. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides. Mol Cells 28: 341-345.
40. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y, Seto M. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087.
41. Ouellet DL, Provost P. 2010. Current knowledge of MicroRNAs and noncoding RNAs in virus-infected cells. Methods Mol Biol 623: 35-65.
42. Pall GS, Codony-Servat C, Byrne J, Ritchie L, Hamilton A. 2007. Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot. Nucleic Acids Res 35: e60.
43. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
44. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A. 2011. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 39: 5157-5163.
45. Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, Meng S. 2010. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 398: 771-777.
46. Quasdorff M, Protzer U. 2010. Control of hepatitis B virus at the level of transcription. J Viral Hepat 17: 527-536.
47. Ramkissoon SH, Mainwaring LA, Sloand EM, Young NS, Kajigaya S. 2006. Nonisotopic detection of microRNA using digoxigenin labeled RNA probes. Mol Cell Probes 20: 1-4.
48. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507-1517.
49. Roberts AP, Lewis AP, Jopling CL. 2011. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 39: 7716-7729.
50. Schmittgen TD, Jiang J, Liu Q, Yang L. 2004. A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res 32: e43.
51. Seeger C, Mason WS. 2000. Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
52. Sells MA, Chen ML, Acs G. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84: 1005-1009.
53. Shi YH, Shi CH. 2009. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15: 3099-3105.
54. Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y, Aoki T, Murakami Y, Toyoda H, Kumada T. 2010. Deregulation of miR 92a expression is implicated in hepatocellular carcinoma development. Pathol Int 60: 351-357.
55. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, Lemon SM. 2012. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci USA 109: 941-946.
56. Sommer G, Heise T. 2008. Posttranscriptional control of HBV gene expression. Front Biosci 13: 5533-5547.
57. Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M. 2007. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 98: 1482-1490.
58. Tang F, Hajkova P, Barton SC, Lao K, Surani MA. 2006. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34: e9.
59. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
60. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG. 2010. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol 53: 57-66.
61. Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E. 2011. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer 105: 146-153.
62. Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H, Han YM, Lee CS, Park JS, Lee CH, Hyun BH, Murakami S, Lee KK. 1999. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 31: 123-132.
63. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H. 2010. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res 88: 169-175.
64. Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, Lu M. 2011. Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology 53: 1476-1485.